There is no need for a third dose of the Chinese Communist Party (CCP) Virus vaccine, the Biden administration has said.

The U.S. Department of Health and Human Services is not convinced that Pfizer’s data provides enough evidence to prove CCP Virus booster shots are necessary to protect Americans from the highly infectious Delta strain.

This was the general consensus of top federal government doctors, after holding a virtual briefing with Pfizer Chief Scientific Officer Mikael Dolsten.

The July 12 meeting came just days after the pharmaceutical giant claimed its doses start wearing off after about six months. The company recommended administering a booster shot for better protection against the disease, and asked the U.S. Food and Drug Administration (FDA) to approve the third jab.

However, the FDA, Centers for Disease Control and Prevention (CDC), and White House chief health advisor Anthony Fauci claimed the booster dose is not necessary at present. They are open to supporting the concept, if more scientific data proves it provides better protection.

“At this time, fully vaccinated Americans do not need a booster shot,” the department said in a statement shared on Twitter. “The vaccines available now offer a very high degree of protection. The administration is prepared for booster doses if, and when, the science demonstrates that they are needed.”

After the briefing Biden officials parroted the same position that there is a lack of overwhelming evidence.

“It was an interesting meeting, they shared their data, [and] there was not anything resembling a decision,” Dr. Fauci said according to U.S. News. “This is just one piece of a much bigger puzzle, and it is one part of the data, so there is not a question of a convincing case one way or the other.”

The department, which convened the meeting, confirmed two doses still offer adequate protection. It stressed that immunizing the unvaccinated population is currently more important than promoting a third shot.

“Any recommendation by CDC and FDA would come after their thorough review process,” the representative said in the statement. “Officials will continue to review any new data, as it becomes available, and will keep the public informed.”

Pfizer had claimed early data from its booster study shows recipient antibody levels increase from fivefold to tenfold with the booster jab compared to those who only had two shots. None of these findings were published at the time of publication, even though the company previously promised to do so.

After the briefing, Pfizer vowed to produce “more definite data” to support its booster shot claims.

“Both Pfizer and the U.S. government share a sense of urgency in staying ahead of the virus that causes COVID-19 (CCP Virus),” company spokeswoman Sharon Castillo said according to Reuters. “We also agree that the scientific data will dictate next steps in the rigorous regulatory process that we always follow.”

The World Health Organization (WHO) previously criticized those promoting the booster dose, and encouraged wealthy nations to prioritize supplying vaccines to disadvantaged countries instead.

“We are making conscious choices right now not to protect those in most need,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement. “Not everywhere is taking the same hit, though. We are in the midst of a growing two-track pandemic where the haves and have-nots, within and between countries, are increasingly divergent.”